Estimating the compliance levels dynamic in hypertensive patients with first-second stage and first-third grades


DOI: https://dx.doi.org/10.18565/therapy.2019.1.60-67

Solovieva K.B., Shalenkova M.A., Dolbin I.V.

City clinical hospital № 38, Nizhny Novgorod
Aim. To estimate the level of compliance and frequency dynamic of various levels in hypertensive patients with stage I-II, grades 1–3: baseline and 12 months after learning at the health school. Material and methods. We examined 65 men with hypertension I-II stage 1-3 grades, middle age is 39,6±7,4 years. The level of compliance was estimated using the “Scale for Estimating Compliance Level in Hypertensive Patients” (SECL-HP), which includes 20 questions, and was determined twice: baseline and 12 months after the patients were learned at the health school «Hypertension». Results. The sum of points for SECL-HP in the first/second survey was (Me [25; 75]): 38 (34; 45)/50 (45; 53) respectively. After learning at the health school the number of patients with a high level of compliance increased [from 1 (1,5%) to 31 (47,7%)], and the number of patients with a low level of compliance decreased [from 36 (55,4%) to 4 (6,15%)]. The frequency of the average level of compliance has not changed: 28 (43,1%) and 30 (46,1%) men, respectively. Conclusion. With the help of scale SECL-HP it is advisable to estimate the adherence in hypertensive patients.
Keywords: compliance levels, compliance, hypertension
Read entire article

Literature


  1. Мачильская О.В. Факторы, определяющие приверженность к лечению больных артериальной гипертензией (обзор литературы). Кардиология и сердечно-сосудистая хирургия. 2016; 9(3): 55–65.

  2. Чукаева И.И. Приверженность лечению больного с артериальной гипертонией. Мед. вестник. [Электронный ресурс].М., 2018 URL: https://medvestnik.ru/content/medarticles/Priverjennost-lecheniu-bolnogo-s-arterialnoi-gipertoniei.html (дата обращения 09.01.2019).

  3. Massimo F., Arno W., Agewall S. et al. European Guidelines on cardiovascular disease prevention in clinical practice. Eur. Heart J. 2016; 37: 2364.

  4. Ho P.M., Bryson C.L., Rumsfeld J.S. Medication adherence: its importance in cardiovascular outcomes. Circulation. 2009;119: 3028–35.

  5. Morisky D.E., Green L.W., Green L. et al. Concurrent and Predictive Validity of a Self-reported Measure of Medication Adherence. Med. Care. 1986; 24(1): 67–74.

  6. Соловьева К.Б., Шаленкова М.А., Долбин И.В. и др. Способ оценки уровня комплаенса больных гипертонической болезнью I–II стадии, 1–3 степени артериальной гипертензии. Патент РФ №2 556 856. 20.07.2015. С. 1–16.

  7. Williams В., Mancia G., Spiering W. et al. ESC/ESH Guidelines for the management of arterial hypertension. Eur. Heart J. 2018; 39: 3021–104.

  8. Бубнова М.Г., Драпкина О.М., Гаврилова Н.Е. и др. Кардиоваскулярная профилактика. Российские рекомендации.М., 2017. С. 71–77.

  9. Школа здоровья. Артериальная гипертония. Под ред. Р.Г. Оганова. Руководство для врачей. М., 2008. 192 с.

  10. Osterberg L., Blaschke T. Adherence to medication. N. Engl. J. Med. 2005; 353: 487–97.


About the Autors

Ksenia B. Solovyova, MD, PhD, General physician of City Clinical hospital (GKB) №38 of Nizhny Novgorod.
Address: 603000, Nizhny Novgorod, 22 Chernyshevskogo St. Tel. +7 (912) 501-00-09. E-mail: Ksyusola@yandex.ru
Maria A. Shalenkova, MD, associate professor, consultant of the City Clinical hospital (GKB) №38 of Nizhny Novgorod. Address: 603000, Nizhny Novgorod, 22 Chernyshevskogo St. Tel. +7 (920) 050-63-53. E-mail: mshalenkova@yandex.ru 
Igor V. Dolbin, MD, associate professor, consultant of the City Clinical hospital (GKB) №38 of Nizhny Novgorod.
Address: 603000, Nizhny Novgorod, 22 Chernyshevskogo St. Tel. +7 (831) 430-34-47.


Similar Articles

Back to Content

Бионика Медиа